Nathaniel Fleming, MD, MS

Title(s)Clinical Fellow, Neurology
SchoolSchool of Medicine
Address675 18th Street, #5142-11
San Francisco CA 94107
Phone415-353-2273
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Risk of dementia in older veterans with multiple sclerosis. Mult Scler Relat Disord. 2024 Feb; 82:105372. Fleming NH, Bahorik A, Xia F, Yaffe K. PMID: 38104510; PMCID: PMC11001267.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors. J Invest Dermatol. 2020 08; 140(8):1609-1618.e7. Chang GA, Wiggins JM, Corless BC, Syeda MM, Tadepalli JS, Blake S, Fleming N, Darvishian F, Pavlick A, Berman R, Shapiro R, Shao Y, Karlin-Neumann G, Spittle C, Osman I, Polsky D. PMID: 32087194; PMCID: PMC7387168.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    3. Outcomes of surgical re-excision versus observation of severely dysplastic nevi: A single-institution, retrospective cohort study. J Am Acad Dermatol. 2020 01; 82(1):238-240. Fleming NH, Shaub AR, Bailey E, Swetter SM. PMID: 31325549.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins. JAMA Dermatol. 2018 12 01; 154(12):1401-1408. Kim CC, Berry EG, Marchetti MA, Swetter SM, Lim G, Grossman D, Curiel-Lewandrowski C, Chu EY, Ming ME, Zhu K, Brahmbhatt M, Balakrishnan V, Davis MJ, Wolner Z, Fleming N, Ferris LK, Nguyen J, Trofymenko O, Liu Y, Chen SC, Pigmented Lesion Subcommittee, Melanoma Prevention Working Group. PMID: 30304348; PMCID: PMC6583364.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    5. Impact of primary care provider density on detection and diagnosis of cutaneous melanoma. PLoS One. 2018; 13(7):e0200097. Fleming NH, Grade MM, Bendavid E. PMID: 30005065; PMCID: PMC6044519.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    6. Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi. JAMA Dermatol. 2016 12 01; 152(12):1327-1334. Fleming NH, Egbert BM, Kim J, Swetter SM. PMID: 27542070.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    7. Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma. J Med Genet. 2015 Apr; 52(4):231-9. Rendleman J, Vogelsang M, Bapodra A, Adaniel C, Silva I, Moogk D, Martinez CN, Fleming N, Shields J, Shapiro R, Berman R, Pavlick A, Polsky D, Shao Y, Osman I, Krogsgaard M, Kirchhoff T. PMID: 25604082; PMCID: PMC5166523.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    8. Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines? J Natl Compr Canc Netw. 2014 Dec; 12(12):1706-12. Gumaste PV, Fleming NH, Silva I, Shapiro RL, Berman RS, Zhong J, Osman I, Stein JA. PMID: 25505211; PMCID: PMC4469335.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    9. Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients. Cancer. 2015 Jan 01; 121(1):51-9. Fleming NH, Zhong J, da Silva IP, Vega-Saenz de Miera E, Brady B, Han SW, Hanniford D, Wang J, Shapiro RL, Hernando E, Osman I. PMID: 25155861; PMCID: PMC4270907.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    10. PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition. Mol Cancer Res. 2014 Mar; 12(3):433-9. Gold HL, Wengrod J, de Miera EV, Wang D, Fleming N, Sikkema L, Kirchhoff T, Hochman T, Goldberg JD, Osman I, Gardner LB. PMID: 24336958; PMCID: PMC3962698.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    11. Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis. Melanoma Res. 2013 Dec; 23(6):461-7. Qian M, Ma MW, Fleming NH, Lackaye DJ, Hernando E, Osman I, Shao Y. PMID: 24165034; PMCID: PMC4419696.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    12. Impact of age on the management of primary melanoma patients. Oncology. 2013; 85(3):173-81. Fleming NH, Tian J, Vega-Saenz de Miera E, Gold H, Darvishian F, Pavlick AC, Berman RS, Shapiro RL, Polsky D, Osman I. PMID: 24008821; PMCID: PMC3842185.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Nathaniel's Networks
    Concepts (81)
    Derived automatically from this person's publications.
    _
    Co-Authors (2)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _